<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>08</Day>
				</PubDate>
			</Journal>
<ArticleTitle>THE EFFECT OF VITAMIN E SUPPLEMENTATION ON LIPID PROFILE AND OXIDATIVE STRESS MARKERS IN HEMODIALYSIS PATIENTS</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10099</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Seyyed Gholamreza</FirstName>
					<LastName>Mortzzavimoghaddam</LastName>
<Affiliation>MD, Department of Internal Medicine, Vali-e-asr Hospital, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Asghar</FirstName>
					<LastName>Zarban</LastName>
<Affiliation>PhD, Department of Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mohammadreza</FirstName>
					<LastName>Rezvani</LastName>
<Affiliation>MD, Department of Internal Medicine, Vali-e-asr Hospital, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>Abstract INTRODUCTION: Dyslipidemia and oxidative stress are thought to be important mechanisms in pathogenesis of disease in hemodialysis patients. This study was designed to investigate the efficacy of oral vitamin E supplementation on lipid profile and oxidative stress in hemodialysis patients. METHODS: The study group consisted of 26 uremic patients (10 women and 16 men), 16-68 years of age undergoing maintenance hemodialysis three times a week (12 hours/week), lasting a range of 6-108 months, at Vali-e-Asre Hospital in Birjand (Iran). Total Antioxidant Capacity (TAC), lipid peroxidation, cholesterol, triglyceride, high-density lipoprotein and low-density lipoprotein levels were determined before and after oral vitamin E supplementation, 400 mg/d for 90 days. RESULTS: Vitamin E supplementation caused a significant decrease in ThioBarbituric Acid Reactive Substances (TBARS) level as a marker for lipid peroxidation (2.97±0.52 vs. 2.55±0.44, P&lt;0.001) and a significant increase in plasma TAC (1252±348 vs. 1398±372, P&lt;0.01). Although there was a decrease in the level of lipid profile, there were no statistically significant differences in the means of cholesterol, triglyceride, high-density lipoprotein and low-density lipoprotein before and after vitamin E supplementation among patients. CONCLUSION: Our results indicated that oral vitamin E supplementation might be able to modify oxidative stress by an increase in TAC, and a decrease in lipid peroxidation; that could be considered as a preventive strategy in hemodialysis patients          Keywords: Antioxidant capacity, lipid peroxidation, lipid profile, vitamin E, hemodialysis.  </Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10099_995ca733e3657ff9f5f3c823d73371e1.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
